| UCLA DA 240.02: Expenditures Against Firm Commitments Under Contracts and Grants |
|---|
| Date: |
August 05, 2011
|
| From: | Chancellor Gene D. Block |
| To: | Executive Vice Chancellor & Provost Scott L. Waugh Vice Chancellor for Research James S. Economou Associate Vice Chancellor, Research Administration Marcia Smith Associate Vice Chancellor & Chief Medical Officer Medical Services, Medical Sciences J. Thomas Rosenthal Assistant Vice Chancellor, Research Ann Pollack Director of Licensing Emily Loughran Director, Office of Contract & Grant Administration Patti Manheim Director, Clinical Trials Contract Unit Helene Orescan Director, Industry Sponsored Research and Material Transfer Brian Roe Senior Contract & Grant Officers Contract & Grant Officers Industry Contract Officers Clinical Trial Contract Officers Senior Grant Analysts Contract Grant Analysts |
| References: |
|
| Supersedes: | UCLA DA 240.01 (Expenditures Against Firm Commitments Under Contracts and Grants) to EVC & Provost Neuman, et al., dated 2/22/2006. |
For guidance in interpreting what constitutes a "firm commitment," General Counsel has provided the following:
While firm commitment has no legal definition, it is obviously something less than a contract. The phrase is applicable to situations where University personnel are advised by representatives of Government agencies that a contract or grant will be forthcoming, and the only delay is a ministerial one of document processing. An agency representative making such a presentation must be one who can be relied on for such representation.This delegation is being reissued due to organization changes and there no substantive changes to the delegation being superseded. This authority may not be further redelegated.
| cc: | Administrative Vice Chancellor Associate Vice Chancellor, Corporate Financial Services Manager, Administrative Policies & Delegations |
Print